The upcoming trial will begin later this month and examine the effects of food on oxycodone pharmacokinetics following 40-milligram doses of the drug, according to data on the FDA website and ClinicalTrials.gov, an online database managed by the U.S. National Institutes of Health tracking drug and medical device trials. The study also will measure effectiveness of Remoxy compared with other. Pfizer knows what they are doing!
Whoever thinks this is a Ponzi is a MORON and Short.
Great buying opp prior to PR which is very likely near term with a PT of 8!